# Neurovalens Limited

- Location (FDA's records): Portglenone, GB
- FDA decisions: 3 (2023–2026): 2 510(k) clearances and 1 De Novo grant
- Names in FDA's records: Neurovalens Limited (2); Neurovalens , Ltd. (1)
- Product codes: QJQ (2), SHX (1)
- Predicates its devices cite: 4 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Neuro-Fitness, LLC: 2 (https://510kreport.com/company/neuro-fitness)
- Electromedical Products, Inc.: 2 (https://510kreport.com/company/electromedical-products)

## Firms that cite its devices most
- Neurofield, Inc.: 1 (https://510kreport.com/company/neurofield)

## Its most-cited devices
- K230826: Modius Sleep (2023), cited by 1

## Recent decisions
- DEN250013: Modius Spero (May 8, 2026)
- K232253: Modius Stress (Mar 27, 2024)
- K230826: Modius Sleep (Oct 27, 2023)

Source page: https://510kreport.com/company/neurovalens